PLAT and hematocrit: HT patients had remarkably higher admission NIHSS compared with patients without HT in general (HG 0.96, CI 0.48–1.45), and in the subpopulation of IV-tPA treated patients in particular (HG 0.93, CI 0.36–1.51).